Raised cardiac troponins

Abstract

References ↵ Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al . ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102: 1193–209. ↵ Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction . J Am Coll Cardiol 2000; 36: 959–69. ↵ Ammann P, Fehr T, Minder EI, Gunter C, Bertel O . Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27: 965–9. ↵ Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA . The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001; 38: 478–85. ↵ Shave R, Dawson E, Whyte G, George K, Ball D, Collinson P, et al . The cardiospecificity of the third-generation troponin T assay after exercise-induced muscle damage. Med Sci Sports Exerc 2002; 34: 651–4. ↵ Tucker JF, Collins RA, Anderson AJ, Hauser J, Kalas J, Apple FS . Early diagnostic efficiency of cardiac troponin I and Troponin T for acute myocardial infarction. Acad Emerg Med 1997; 4: 13–21. ↵ Bertinchant JP, Larue C, Pernel I, Ledermann B, Fabbro-Peray P, Beck L, et al . Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem 1996; 29: 587–94. ↵ Christenson RH, Apple FS, Morgan DL, Alonsozana GL, Mascotti K, Olson M, et al . Cardiac troponin I measurement with the ACCESS immunoassay system: analytical and clinical performance characteristics. Clin Chem 1998; 44: 52–60. ↵ Hamm CW . New serum markers for acute myocardial infarction. N Engl J Med 1994; 331: 607–8. ↵ Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D . Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989; 169: 1977–91. ↵ Piper HM, Schwartz P, Spahr R, Hütter JF, Spieckermann PG . Early enzyme release from myocardial cells is not due to irreversible cell damage. J Mol Cell Cardiol 1984; 16: 385–8. ↵ McDonough JL, Arrell DK, Van Eyk JE . Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res 1999; 84: 9–20.